MedPath

Effectiveness of vaginal isosorbide mononitrate for cervical ripening in uncomplicated singleton pregnancies at 39 weeks gestation in an outpatient setting: A randomized controlled trial

Early Phase 1
Completed
Conditions
Induction of labour
Registration Number
SLCTR/2013/030
Lead Sponsor
niversity of Ruhuna
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

1.Uncomplicated pregnancy at 39 weeks POG
2.Singleton fetus having a cephalic presentation
3. Modified Bishop's Score <5
4.Consenting to self-administer the vaginal tablets every other day for five doses.

Exclusion Criteria

1.Any pregnancy complications e.g. Pregnancy Induced Hypertension, Gestational Diabetes Melitus
2.Multiple pregnancies
3.Planned Caesarean section
4.Fetal Growth Restriction
5.History of hypersensitivity or idiosyncratic reaction to nitrates.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.